RNAC (NASDAQ) - Dividend History and Outstanding Shares

No Dividends discovered - So far (until May 2024) RNAC does not pay dividends. Outstanding Shares evolving.

No Dividends
As of May 2024, Cartesian Therapeutics (RNAC) does not pay a dividend.

Outstanding Shares

What is the Trend of RNAC`s Outstanding Shares?

The Outstanding Shares of Cartesian Therapeutics are growing at a rate of 55.18% per year on average over the last 10 years. The Correlation Coefficent of the Outstanding Shares is 100.00%. Investors should be aware that the price of a stock often is negatively affected by an increasing number of shares.

Did Cartesian Therapeutics ever had a Stock Split?

Yes, last Stock Split was on 2024-04-05 with a factor of 1:30. This reverse stock split decreased the number of shares and increased the price per share by a ratio of 0.03.

Year Number of Shares (Mill.) Growth
2023 161.93 +11%
2022 145.87 +17.59%
2021 124.06 +15.02%
2020 107.86 +106.14%
2019 52.32 +133.05%
2018 22.45 +0.82%
2017 22.27 +21.92%
2016 18.27 +41.94%
2015 12.87 +543.43%
2014 2

Dividend Yields, Growth & Consistency

Overall Dividend Rating -
Dividends Paid 12m - Yield 12m -
Dividends Paid Average 5y - Yield Average 5y -
Growth Rate 5y - Yield on Cost 5y -
Payout Consistency - First Payout -
Compare RNAC Dividends with its Industry Peers

No Dividends Paid

-

  • RNAC`s 0.00% Dividend Yield is calculated by dividing the dividend payments of the last 12-Months (TTM) of 0.00 by the current stock price.
  • 0.00% Yield on Cost is the effective dividend income you'd receive today if you purchased the stock five years ago (Rate of the last 12 Months 0.00 divided by price 5 years ago).
  • The 0.0% Payout Consistency of RNAC Dividends gauges Stability (Values above 80%) or Fragility (Values under 60%).
  • The Average Dividend Growth Rate of 0.00% per year in the last 5-Years showcases RNAC`s commitment to shareholders. Steady or increasing dividends over time can be a sign of a healthy financial outlook.
The Overall Dividend Rating of 0.00 is quantified on a scale from 0 to +10.
Ratings surpassing 5 are regarded as favorable, while those exceeding 7.5 are exceptionally strong. The calculations includes: Yield, Yield on Cost, Consistency of Payouts and Growth Rates over time.